DekaBank Deutsche Girozentrale Sells 19,590 Shares of Waters Corporation $WAT

DekaBank Deutsche Girozentrale cut its stake in Waters Corporation (NYSE:WAT) by 25.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 56,576 shares of the medical instruments supplier’s stock after selling 19,590 shares during the quarter. DekaBank Deutsche Girozentrale owned about 0.10% of Waters worth $19,838,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in WAT. Brighton Jones LLC increased its holdings in shares of Waters by 112.9% in the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after acquiring an additional 673 shares during the period. GAMMA Investing LLC increased its holdings in shares of Waters by 36.6% in the 1st quarter. GAMMA Investing LLC now owns 1,797 shares of the medical instruments supplier’s stock valued at $662,000 after acquiring an additional 481 shares during the period. Wealth Enhancement Advisory Services LLC grew its stake in Waters by 169.1% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 11,619 shares of the medical instruments supplier’s stock worth $4,283,000 after buying an additional 7,301 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in Waters by 4.1% during the 1st quarter. Janney Montgomery Scott LLC now owns 4,813 shares of the medical instruments supplier’s stock worth $1,774,000 after buying an additional 189 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. grew its stake in Waters by 4.6% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,986 shares of the medical instruments supplier’s stock worth $1,101,000 after buying an additional 130 shares during the last quarter. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Waters and gave the stock a “hold” rating in a research report on Tuesday, August 5th. UBS Group reaffirmed a “neutral” rating on shares of Waters in a research report on Tuesday, July 15th. JPMorgan Chase & Co. lifted their price target on Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Scotiabank reaffirmed a “sector outperform” rating and set a $465.00 price target on shares of Waters in a research report on Friday, July 11th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $376.80.

Waters Price Performance

WAT stock opened at $349.04 on Thursday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. The business has a 50 day simple moving average of $308.96 and a 200-day simple moving average of $323.22. The firm has a market capitalization of $20.78 billion, a PE ratio of 31.47, a price-to-earnings-growth ratio of 3.24 and a beta of 1.04. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56.

Waters (NYSE:WAT) last posted its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business had revenue of $608.55 million during the quarter. Equities research analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.